Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Breast Neoplasms × dabrafenib × Clear all

Sponsor

Conditions

Neoplasms 3 Glioma 2 Thyroid Carcinoma, Anaplastic 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Melanoma 1 Leukemia, Hairy Cell 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Astrocytoma 1

Interventions

Trastuzumab 6 Fulvestrant 6 Capecitabine 6 abemaciclib 5 trastuzumab deruxtecan 4 eribulin 4 Paclitaxel 4 Gemcitabine 4 sacituzumab govitecan 3 Vinorelbine 3 Docetaxel 3 Cyclophosphamide 3 selpercatinib 2 ribociclib 2 pertuzumab 2 olaparib 2 exemestane 2 Letrozole 2 Fluorouracil 2 Epirubicin 2 Doxorubicin 2 Anastrozole 2 Ado-Trastuzumab Emtansine 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 talazoparib 1 palbociclib 1 neratinib 1 larotrectinib 1 inavolisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡